Butterbur: An evidence-based systematic review by the natural standard research collaboration

Journal of Herbal Pharmacotherapy

Volumn 5, Issue 3, 2005, Pages 119-143

  Giles, Mary ^a   Ulbricht, Catherine ^b   Khalsa, Kara Purkh Singh ^c   DeFranco Kirkwood, Catherine ^d   Park, Christine ^e   Basch, Ethan ^f  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BASTYR UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e NORTHEASTERN UNIVERSITY   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Blatterdock; Langwort; Petadolor H; Petasitidis folium (flower); Wild rhubarb

Indexed keywords

ALIMEMAZINE; AMANTADINE; AMITRIPTYLINE; ATROPINE; BETHANECHOL; BIPERIDEN; BROMPHENIRAMINE; CARBINOXAMINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYPROHEPTADINE; DICYCLOVERINE; DIPHENHYDRAMINE; FEXOFENADINE; HALOPERIDOL; HYOSCYAMINE; IPRATROPIUM BROMIDE; LEVOMEPROMAZINE; OLANZAPINE; PERPHENAZINE; PETAFORCE; PETASITES HYBRIDUS EXTRACT; PIMOZIDE; PLACEBO; PLANT EXTRACT; PROMAZINE; PROMETHAZINE; QUINIDINE; SCOPOLAMINE; TESALIN; TRIPROLIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZE 339;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ASTHMA; CARCINOGENICITY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COCHRANE LIBRARY; CONSTIPATION; DROWSINESS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DYSPHAGIA; DYSPNEA; EMBASE; ETHNIC GROUP; EVIDENCE BASED MEDICINE; FATIGUE; FLOWER; GASTROINTESTINAL SYMPTOM; HUMAN; INFORMATION RETRIEVAL; LIVER TOXICITY; META ANALYSIS; MIGRAINE; NAUSEA AND VOMITING; NONHUMAN; PETASITES; PETASITES HYBRIDUS; PRIORITY JOURNAL; PRURITUS; REVIEW; RHIZOME; RISK REDUCTION; SCIENTIFIC LITERATURE; SKIN ALLERGY; SKIN DISCOLORATION; SMOOTH MUSCLE RELAXATION; STATISTICAL ANALYSIS; STOMACH PAIN; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TUSSILAGO; VASODILATATION;

ANIMALS; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HUMANS; PETASITES; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RESEARCH DESIGN;

EID: 33745307530     PISSN: 15228940     EISSN: 15229106     Source Type: Journal    
DOI: 10.1300/J157v05n03_12     Document Type: Review

References (20)

1. Debrunner B, Meier B. Petasites hybridus: A tool for interdisciplinary research in phytotherapy. Pharm Acta Helv 1998;72(6):359-362.
2. Brune K, Bickel D, Peskar BA. Gastro-protective effects by extracts of Petasites hybridus: The role of inhibition of peptido-leukotriene synthesis. Planta Med 1993; 59(6):494-496.
3. Anon. Review. Petasites hybridus. Altern Med Rev 2001;6(2):207-209.
4. Grossman W, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Altern Med Rev 2001;6(3):303-310.
5. Brattstrom A. A newly developed extract (Ze 339) from butterbur (Petasites hybridus L.) is clinically efficient in allergic rhinitis (hay fever). Phytomedicine 2003;10 Suppl 4:50-52.
6. Gray RD, Haggart K, Lee DK, et al. Effects of butterbur treatment in intermittent allergic rhinitis: A placebo-controlled evaluation. Ann Allergy Asthma Immunol 2004; 93(1):56-60.
7. Lee DK, Gray RD, Robb FM, et al. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis. Clin Exp Allergy 2004;34(4):646-649.
8. Lee DK, Carstairs IJ, Haggart K, et al. Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis. Clin Exp Allergy 2003;33(7):882-886.
9. Schapowal A. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. BMJ 2002;324(7330):144-146.
10. Thomet OA, Schapowal A, Heinisch IV, et al. Anti-inflammatory activity of an extract of Petasites hybridus in allergic rhinitis. Int Immunopharmacol 2002;2(7): 997-1006.
11. Danesch UC. Petasites hybridus (Butterbur root) extract in the treatment of asthma - an open trial. Altern Med Rev 2004;9(1):54-62.
12. Grossmann M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther 2000;38(9):430-435.
13. Lipton RB, Gobel H, Einhaupl KM, et al. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 2004;63(12):2240-2244.
14. Bickel D, Roder T, Bestmann HJ, et al. Identification and characterization of inhibitors of peptido-leukotriene-synthesis from Petasites hybridus. Planta Med 1994; 60(4):318-322.
15. Fiebich BL, Grozdeva M, Hess S, et al. Petasites hybridus extracts in vitro inhibit COX-2 and PGE2 release by direct interaction with the enzyme and by preventing p42/44 MAP kinase activation in rat primary microglial cells. Planta Med 2005;71(1): 12-19.
16. Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 2004;51(2):89-97.
17. Canada) Schweiz Zschr GanzheitsMedizin 1995;7(7/ 8):365-370.
18. Danesch U, Rittinghausen R. Safety of a patented special butterbur root extract for migraine prevention. Headache 2003;43(1):76-78.
19. Jackson CM, Lee DK, Lipworth BJ. The effects of butterbur on the histamine and allergen cutaneous response. Ann Allergy Asthma Immunol 2004;92(2):250-254.
20. Lee DK, Haggart K, Robb FM, et al. Butterbur, a herbal remedy, confers complementary anti-inflammatory activity in asthmatic patients receiving inhaled corticosteroids. Clin Exp Allergy 2004;34(1):110-114.